Hem › Diffust storcelligt B-cellslymfom › North Carolina › Durham
Kliniska studier för Diffust storcelligt B-cellslymfom i Durham, NC
14 studier för Diffust storcelligt B-cellslymfom söker deltagare vid platser i och runt Durham (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
RekryterarFas 2
- Duke Blood Cancer Center, Durham
A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma
RekryterarFas 3
- Duke University Medical Center, Durham
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
RekryterarFas 2
- University of North Carolina Medical Center ( Site 0136), Chapel Hill · 10 mi bort
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
RekryterarFas 1/2
- University of North Carolina at Chapel Hill/ University of North Carolina Medical Center, Chapel Hill · 10 mi bort
Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU
RekryterarObservationsstudie
- Duke University Medical Center - Division of Hematologic Malignancies, Durham
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
RekryterarFas 3
- Duke Cancer Institute, Durham
DALY II USA/ MB-CART2019.1 for DLBCL
RekryterarFas 2
- Duke University Medical Center - Division of Hematologic Malignancies, Durham
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
RekryterarFas 1
- Duke University Medical Center, Durham
Registry of Older Patients With Cancer
RekryterarObservationsstudie
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mi bort
Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.
RekryterarFas 1
- Duke Univerisity, Durham
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
RekryterarObservationsstudie
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mi bort
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
RekryterarFas 1
- University of North Carolina, Chapel Hill · 10 mi bort
A Study of NX-1607 in Adults With Advanced Malignancies
RekryterarFas 1
- University of North Carolina, Chapel Hill · 10 mi bort
Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy
RekryterarFas 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi bort
Diffust storcelligt B-cellslymfom-studier i andra städer
- New York City, NY21 studier
- Baldwin Park, CA19 studier
- Chicago, IL18 studier
- Houston, TX17 studier
- Los Angeles, CA17 studier
- Boston, MA16 studier
- Milwaukee, WI16 studier
- Nashville, TN15 studier
- Portland, OR15 studier
- Philadelphia, PA15 studier
- Dallas, TX13 studier
- Seattle, WA12 studier
Andra studier i Durham
- Bröstcancer63 studier
- Cancer (alla typer)58 studier
- Icke-småcellig lungcancer39 studier
- Multipelt myelom37 studier
- Metastaserande cancer33 studier
- Akut myeloid leukemi33 studier
- Lungcancer32 studier
- Prostatacancer32 studier
- Kolorektal cancer28 studier
- Kronisk lymfatisk leukemi27 studier
- Äggstockscancer27 studier
- Hjärtsvikt26 studier
Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.